These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4820358)

  • 1. Editorial: Dr. Jekyll and Mr. Hyde.
    Feldmann EG
    J Pharm Sci; 1974 Mar; 63(3):1. PubMed ID: 4820358
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial: The FDA and the pharmacist as an advisor on nonprescription drugs.
    Zellmer WA
    Am J Hosp Pharm; 1974 May; 31(5):447. PubMed ID: 4829385
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA OTC advisory group needs practitioners.
    Jellin JM
    Am Pharm; 1993 Apr; NS33(4):4, 90. PubMed ID: 8475854
    [No Abstract]   [Full Text] [Related]  

  • 4. OTC labeling reform.
    J Am Pharm Assoc (Wash); 1997; NS37(6):619-20. PubMed ID: 9425787
    [No Abstract]   [Full Text] [Related]  

  • 5. Safe & sound. Interview by Helena Gail Rubinstein.
    Woodcock J
    AHIP Cover; 2009; 50(2):38-43. PubMed ID: 19385317
    [No Abstract]   [Full Text] [Related]  

  • 6. Is three a crowd or company?: Behind-the-counter drugs.
    Barth AS
    Food Drug Law J; 2008; 63(4):865-89. PubMed ID: 19601386
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: To cough or not to cough.
    J Am Osteopath Assoc; 1973 Dec; 73(4):268-70. PubMed ID: 4491950
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: Harmless, but ineffective, remedies.
    Feldmann EG
    J Pharm Sci; 1975 Oct; 64(10):I. PubMed ID: 1185526
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: Safe and sane use of OTC's.
    Tice LF
    Am J Pharm Sci Support Public Health; 1973; 145(6):187-8. PubMed ID: 4768815
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial: Reductio ad absurdum.
    Tice LF
    Am J Pharm Sci Support Public Health; 1973; 145(5):153-4. PubMed ID: 4753129
    [No Abstract]   [Full Text] [Related]  

  • 11. The anesthesiologist: from Mr. Hyde to Dr. Jekyll.
    Thomas BJ
    RN; 1974 Jan; 37(1):46-53. PubMed ID: 4492376
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: Methaqualone--a Dr. Jekyll and Mr. Hyde?
    Ostrenga JA
    Clin Toxicol; 1973; 6(4):607-9. PubMed ID: 4799567
    [No Abstract]   [Full Text] [Related]  

  • 13. The FDA takes action against unapproved drugs.
    Meadows M
    FDA Consum; 2007; 41(1):34-5. PubMed ID: 17342837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rx-to-OTC shift: not for these widely used drugs.
    Chase SL
    RN; 1995 Jan; 58(1):67. PubMed ID: 7624708
    [No Abstract]   [Full Text] [Related]  

  • 15. Panel recommends limits on alcohol content of nonprescription products. FDA Over-The-Counter Drugs Advisory Committee.
    Am J Hosp Pharm; 1993 Mar; 50(3):400. PubMed ID: 8442445
    [No Abstract]   [Full Text] [Related]  

  • 16. Steps taken to lessen tampering with OTC drugs.
    FDA Drug Bull; 1983 Apr; 13(1):6. PubMed ID: 6852409
    [No Abstract]   [Full Text] [Related]  

  • 17. The American College of Allergists and the Food and Drug Administration.
    Boggs PB
    Ann Allergy; 1986 Jun; 56(6):443. PubMed ID: 3717709
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of the courts in drug decisions.
    Archambault GF
    Hosp Formul; 1977 Apr; 12(4):272. PubMed ID: 10236475
    [No Abstract]   [Full Text] [Related]  

  • 19. Rx drugs switched to OTC.
    FDA Drug Bull; 1983 Nov; 13(3):29-30. PubMed ID: 6653955
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct-to-OTC marketing of drugs: possible approaches.
    Mahinka SP; Bierman ME
    Food Drug Law J; 1995; 50(1):49-63. PubMed ID: 10342985
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.